These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 7890748

  • 1. A camptothecin-resistant DNA topoisomerase I mutant exhibits altered sensitivities to other DNA topoisomerase poisons.
    Knab AM, Fertala J, Bjornsti MA.
    J Biol Chem; 1995 Mar 17; 270(11):6141-8. PubMed ID: 7890748
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants.
    Knab AM, Fertala J, Bjornsti MA.
    J Biol Chem; 1993 Oct 25; 268(30):22322-30. PubMed ID: 8226741
    [Abstract] [Full Text] [Related]

  • 3. Covalent and noncovalent DNA binding by mutants of vaccinia DNA topoisomerase I.
    Morham SG, Shuman S.
    J Biol Chem; 1992 Aug 05; 267(22):15984-92. PubMed ID: 1322412
    [Abstract] [Full Text] [Related]

  • 4. An engineered mutant of vaccinia virus DNA topoisomerase I is sensitive to the anti-cancer drug camptothecin.
    Gupta M, Zhu CX, Tse-Dinh YC.
    J Biol Chem; 1992 Dec 05; 267(34):24177-80. PubMed ID: 1332948
    [Abstract] [Full Text] [Related]

  • 5. Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine.
    Benedetti P, Fiorani P, Capuani L, Wang JC.
    Cancer Res; 1993 Sep 15; 53(18):4343-8. PubMed ID: 8395982
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity.
    Fiorani P, Amatruda JF, Silvestri A, Butler RH, Bjornsti MA, Benedetti P.
    Mol Pharmacol; 1999 Dec 15; 56(6):1105-15. PubMed ID: 10570037
    [Abstract] [Full Text] [Related]

  • 8. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.
    Eng WK, Faucette L, Johnson RK, Sternglanz R.
    Mol Pharmacol; 1988 Dec 15; 34(6):755-60. PubMed ID: 2849043
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. SCT1 mutants suppress the camptothecin sensitivity of yeast cells expressing wild-type DNA topoisomerase I.
    Kauh EA, Bjornsti MA.
    Proc Natl Acad Sci U S A; 1995 Jul 03; 92(14):6299-303. PubMed ID: 7603986
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization of an altered DNA catalysis of a camptothecin-resistant eukaryotic topoisomerase I.
    Gromova II, Kjeldsen E, Svejstrup JQ, Alsner J, Christiansen K, Westergaard O.
    Nucleic Acids Res; 1993 Feb 11; 21(3):593-600. PubMed ID: 8382801
    [Abstract] [Full Text] [Related]

  • 13. Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line.
    Urasaki Y, Laco GS, Pourquier P, Takebayashi Y, Kohlhagen G, Gioffre C, Zhang H, Chatterjee D, Pantazis P, Pommier Y.
    Cancer Res; 2001 Mar 01; 61(5):1964-9. PubMed ID: 11280753
    [Abstract] [Full Text] [Related]

  • 14. DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin.
    Wright CM, van der Merwe M, DeBrot AH, Bjornsti MA.
    J Biol Chem; 2015 May 08; 290(19):12068-78. PubMed ID: 25795777
    [Abstract] [Full Text] [Related]

  • 15. Yeast Saccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecin.
    Bjornsti MA, Knab AM, Benedetti P.
    Cancer Chemother Pharmacol; 1994 May 08; 34 Suppl():S1-5. PubMed ID: 8070016
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of human topoisomerase I in baby hamster kidney cells: hypersensitivity of clonal isolates to camptothecin.
    Madden KR, Champoux JJ.
    Cancer Res; 1992 Feb 01; 52(3):525-32. PubMed ID: 1310066
    [Abstract] [Full Text] [Related]

  • 17. Cloning of Chinese hamster DNA topoisomerase I cDNA and identification of a single point mutation responsible for camptothecin resistance.
    Tanizawa A, Beitrand R, Kohlhagen G, Tabuchi A, Jenkins J, Pommier Y.
    J Biol Chem; 1993 Dec 05; 268(34):25463-8. PubMed ID: 8244980
    [Abstract] [Full Text] [Related]

  • 18. Directed evolution to increase camptothecin sensitivity of human DNA topoisomerase I.
    Scaldaferro S, Tinelli S, Borgnetto ME, Azzini A, Capranico G.
    Chem Biol; 2001 Sep 05; 8(9):871-81. PubMed ID: 11564555
    [Abstract] [Full Text] [Related]

  • 19. The camptothecin-resistant topoisomerase I mutant F361S is cross-resistant to antitumor rebeccamycin derivatives. A model for topoisomerase I inhibition by indolocarbazoles.
    Bailly C, Carrasco C, Hamy F, Vezin H, Prudhomme M, Saleem A, Rubin E.
    Biochemistry; 1999 Jul 06; 38(27):8605-11. PubMed ID: 10393535
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.